Eyenovia Appoints Three Industry Veterans to Board of Directors
Mar 26, 2018 20:05 pm UTC| Business
NEW YORK, March 26, 2018 -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver...
TSS, Inc. Reports Fourth Quarter and 2017 Results
Mar 26, 2018 20:02 pm UTC| Business
ROUND ROCK, Texas, March 26, 2018 -- TSS, Inc. (Other OTC:TSSI), a data center facilities and technology services company, reported results for its fourth quarter and fiscal year ended December 31, 2017. ...
Mar 26, 2018 20:02 pm UTC| Business
Montrouge, France, March 26, 2018 DBV Technologies Announces Closing of Underwriters' Option to Purchase Additional Shares in Global Offering DBV Technologies (the "Company") (Euronext: DBV - ISIN: FR0010417345 -...
Landmark Infrastructure Partners LP Announces Launch of Public Offering of Series C Preferred Units
Mar 26, 2018 20:01 pm UTC| Business
EL SEGUNDO, Calif., March 26, 2018 -- Landmark Infrastructure Partners LP (Nasdaq:LMRK) (the “Partnership”) announced today that it has commenced an underwritten public offering of Series C Floating-to-Fixed Rate...
Gladstone Land Corporation Announces Common Stock Offering
Mar 26, 2018 20:01 pm UTC| Business
MCLEAN, Va., March 26, 2018 -- Gladstone Land Corporation (NASDAQ:LAND) (the “Company”) today announced that it plans to sell shares of its common stock in an underwritten public offering. The Company also plans to...
Overstock.com Announces Proposed Public Offering of Common Stock
Mar 26, 2018 20:01 pm UTC| Business
SALT LAKE CITY, March 26, 2018 -- Overstock.com, Inc. (NASDAQ:OSTK) today announced that it intends to offer 4,000,000 shares of its common stock in an underwritten public offering. Overstock also expects to grant to...
MacroGenics Announces Proposed Public Offering of Common Stock
Mar 26, 2018 20:01 pm UTC| Business
ROCKVILLE, MD, March 26, 2018 -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of...